Privosegtor
Privosegtor is an investigational new drug that is being evaluated by Oculis Pharma for the treatment of optic neuritis.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Privosegtor is an investigational new drug that is being evaluated by Oculis Pharma for the treatment of optic neuritis. It is a serine/threonine-protein kinase SGK2 activator that is claimed to have neuroprotective properties.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1365631173 under CC BY-SA 4.0; modifications have been made.